Viewing Study NCT01884259

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:05 PM
Ignite Modification Date: 2026-06-01 @ 1:45 PM
Study NCT ID: NCT01884259
Status: COMPLETED
Last Update Posted: 2022-05-26
First Post: 2012-05-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Induction Chemotherapy With TP+5-FU or TP+Cetuximab Followed by Radioimmuptherapy for Locally Advanced or Not Resectable SCCHNN
Sponsor: Arbeitsgemeinschaft medikamentoese Tumortherapie
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Squamous Cell Carcinoma of the Hypopharynx Stage III View
None Squamous Cell Carcinoma of the Hypopharynx Stage IV View
None Squamous Cell Carcinoma of the Larynx Stage III View
None Squamous Cell Carcinoma of the Larynx Stage IV View
None Squamous Cell Carcinoma of the Oropharynx Stage III View
None Squamous Cell Carcinoma of the Oropharynx Stage IV View
None Squamous Cell Carcinoma of the Oral Cavity Stage III View
None Squamous Cell Carcinoma of the Oral Cavity Stage IV View
Keywords:

Keywords

Keyword Brief Keyword Text View
None local advanced squamous cell carcinoma View
None Larynx View
None Hypopharynx View
None Oropharynx View
None Cavum oris View
None docetaxel View
None cisplatin View
None 5-fluorouracil View
None Cetuximab View